Frank Wydra, MD
Sports Medicine · Aurora, CONPI 1467895623
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,382 of the $20,429 with a category attached, or 60.6%. 24 manufacturers reported payments, led by Arthrex at 30.9% of the total. Reporting peaked in 2019 at $10,992 and has fallen 96.0% since, to $442 in 2025.
Across 134 payments — averaging $152.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$6K
- Gemini Mountain Medical, LLC$6K
- Smith+Nephew$3K
- Stryker$2K
- Medical Device Business Services, Inc.$1K
- Johnson & Johnson$766
- plus $2K from 18 others
Across 9 payments — averaging $5068.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$46K
What the payments were for
- Travel & lodging$2,29411%
- Food & beverage$5,75428%
- Education$12,38261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $6,303 |
| Gemini Mountain Medical, LLC | 15 | $5,630 |
| Smith+Nephew | 13 | $3,019 |
| Stryker | 25 | $1,946 |
| Medical Device Business Services, Inc. | 8 | $1,197 |
| Johnson & Johnson(2 entities) | 20 | $766 |
| Anika Therapeutics, Inc. | 6 | $339 |
| Ferring Pharmaceuticals Inc. | 3 | $178 |
| Encore Medical, LP | 1 | $150 |
| QT Imaging, Inc. | 1 | $147 |
| Skeletal Dynamics Inc | 1 | $133 |
| SPR Therapeutics, Inc | 1 | $99 |
| Bioventus LLC | 6 | $98 |
| Illuminoss Medical, Inc. | 1 | $78 |
| Medtronic | 1 | $65 |
| Pacira Pharmaceuticals Incorporated | 2 | $52 |
| Acumed LLC | 1 | $46 |
| Boston Scientific | 1 | $36 |
| Fidia Pharma USA Inc. | 2 | $34 |
| Medacta USA, Inc. | 2 | $33 |
| Avanos Medical | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Vericel Corporation | 1 | $20 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,429 in reported general payments places this provider in the 70th percentile of 196 sports medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 185 | $611 |
| Naproxen | 36 | $303 |
| Celecoxib | 18 | $155 |
| Amoxicillin | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Aurora
- Rachel FrankAurora$1.6M
- Jonathan BravmanAurora$247K
- Eric McCartyAurora$209K
- Jeffrey HassebrockAurora$69K
- Jamie FriedmanAurora$40K
- Nicholas TsourisAurora$40K
- Jason DragooAurora$39K
- Philip SerbinAurora$37K
- Patrick GarvinAurora$36K
- Andrew KuhnAurora$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.